Table 6. Tumour Characteristics .
DNA=Deoxyribonucleic acid; NCCN=National Comprehensive Cancer Network
| DNA (n = 137) | Acquire 22G (n = 39) | ProCore 22G (n = 40) | ProCore 20G (n = 58) | p-value |
| NCCN Stage | ||||
| Operable, n (%) | 0 (0) | 6 (15) | 4 (7) | 0.326 |
| Borderline resectable, n (%) | 3 (8) | 3 (3) | 6 (10) | |
| Locally advanced, n (%) | 15 (38) | 15 (38) | 19 (33) | |
| Metastatic, n (%) | 19 (49) | 16 (40) | 27 (47) | |
| Tumour location | ||||
| Head, n (%) | 17 (44) | 25 (63) | 34 (59) | 0.279 |
| Neck, n (%) | 5 (13) | 4 (10) | 2 (3) | |
| Body, n (%) | 8 (21) | 3 (8) | 10 (17) | |
| Tail, n (%) | 3 (8) | 2 (5) | 5 (9) | |
| Uncinate, n (%) | 5 (13) | 2 (5) | 2 (3) | |
| Distal, n (%) | 0 (0) | 1 (3) | 2 (3) | |
| Other, n (%) | 0 (0) | 0 (0) | 2 (3) | |
| Presence of onsite Cytology, n (%) | 3 (8) | 38 (95) | 17 (29) | <0.001 |